Search

iRhythm Technologies Inc

Abrir

SetorSaúde

127.24 2.23

Visão Geral

Variação de preço das ações

24h

Atual

Mín

123.51

Máximo

127.16

Indicadores-chave

By Trading Economics

Rendimento

-20M

-14M

Vendas

-9.5M

199M

EPS

-0.35

Margem de lucro

-6.988

Funcionários

2,400

EBITDA

-20M

-3.6M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+40.29% upside

Dividendos

By Acuity

Próximos Ganhos

6 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-453M

3.7B

Abertura anterior

125.01

Fecho anterior

127.24

Sentimento de Notícias

By Acuity

50%

50%

151 / 340 Ranking em Healthcare

iRhythm Technologies Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 20:03 UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31 de jul. de 2026, 21:01 UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30 de jul. de 2026, 19:43 UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29 de jul. de 2026, 19:52 UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28 de jul. de 2026, 18:03 UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27 de jul. de 2026, 20:06 UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24 de jul. de 2026, 20:06 UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23 de jul. de 2026, 09:01 UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21 de jul. de 2026, 18:56 UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20 de jul. de 2026, 19:16 UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Comparação entre Pares

Variação de preço

iRhythm Technologies Inc Previsão

Preço-alvo

By TipRanks

40.29% parte superior

Previsão para 12 meses

Média 174.88 USD  40.29%

Máximo 255 USD

Mínimo 150 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para iRhythm Technologies Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

9 ratings

9

Comprar

0

Manter

0

Vender

Sentimento

By Acuity

151 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat